{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T06:20:18Z","timestamp":1770531618847,"version":"3.49.0"},"reference-count":480,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T00:00:00Z","timestamp":1525305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Tumour cells can adopt telomere maintenance mechanisms (TMMs) to avoid telomere shortening, an inevitable process due to successive cell divisions. In most tumour cells, telomere length (TL) is maintained by reactivation of telomerase, while a small part acquires immortality through the telomerase-independent alternative lengthening of telomeres (ALT) mechanism. In the last years, a great amount of data was generated, and different TMMs were reported and explained in detail, benefiting from genome-scale studies of major importance. In this review, we address seven different TMMs in tumour cells: mutations of the TERT promoter (TERTp), amplification of the genes TERT and TERC, polymorphic variants of the TERT gene and of its promoter, rearrangements of the TERT gene, epigenetic changes, ALT, and non-defined TMM (NDTMM). We gathered information from over fifty thousand patients reported in 288 papers in the last years. This wide data collection enabled us to portray, by organ\/system and histotypes, the prevalence of TERTp mutations, TERT and TERC amplifications, and ALT in human tumours. Based on this information, we discuss the putative future clinical impact of the aforementioned mechanisms on the malignant transformation process in different setups, and provide insights for screening, prognosis, and patient management stratification.<\/jats:p>","DOI":"10.3390\/genes9050241","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T03:08:21Z","timestamp":1525403301000},"page":"241","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":118,"title":["Telomere Maintenance Mechanisms in Cancer"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7410-7869","authenticated-orcid":false,"given":"Tiago Bordeira","family":"Gaspar","sequence":"first","affiliation":[{"name":"Cancer Signaling and Metabolism Group, Institute for Research and Innovation in Health Sciences (i3S), University of Porto, 4200-135 Porto, Portugal"},{"name":"Cancer Signaling and Metabolism Group, Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), 4200-135 Porto, Portugal"},{"name":"Medical Faculty of University of Porto (FMUP), 4200-139 Porto, Portugal"},{"name":"Abel Salazar Biomedical Sciences Institute (ICBAS), University of Porto, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7757-7401","authenticated-orcid":false,"given":"Ana","family":"S\u00e1","sequence":"additional","affiliation":[{"name":"Cancer Signaling and Metabolism Group, Institute for Research and Innovation in Health Sciences (i3S), University of Porto, 4200-135 Porto, Portugal"},{"name":"Cancer Signaling and Metabolism Group, Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), 4200-135 Porto, Portugal"},{"name":"Abel Salazar Biomedical Sciences Institute (ICBAS), University of Porto, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8597-3474","authenticated-orcid":false,"given":"Jos\u00e9 Manuel","family":"Lopes","sequence":"additional","affiliation":[{"name":"Cancer Signaling and Metabolism Group, Institute for Research and Innovation in Health Sciences (i3S), University of Porto, 4200-135 Porto, Portugal"},{"name":"Cancer Signaling and Metabolism Group, Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), 4200-135 Porto, Portugal"},{"name":"Medical Faculty of University of Porto (FMUP), 4200-139 Porto, Portugal"},{"name":"Department of Pathology and Oncology, Centro Hospitalar S\u00e3o Jo\u00e3o, 4200-139 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1613-1235","authenticated-orcid":false,"given":"Manuel","family":"Sobrinho-Sim\u00f5es","sequence":"additional","affiliation":[{"name":"Cancer Signaling and Metabolism Group, Institute for Research and Innovation in Health Sciences (i3S), University of Porto, 4200-135 Porto, Portugal"},{"name":"Cancer Signaling and Metabolism Group, Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), 4200-135 Porto, Portugal"},{"name":"Medical Faculty of University of Porto (FMUP), 4200-139 Porto, Portugal"},{"name":"Department of Pathology and Oncology, Centro Hospitalar S\u00e3o Jo\u00e3o, 4200-139 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9607-6998","authenticated-orcid":false,"given":"Paula","family":"Soares","sequence":"additional","affiliation":[{"name":"Cancer Signaling and Metabolism Group, Institute for Research and Innovation in Health Sciences (i3S), University of Porto, 4200-135 Porto, Portugal"},{"name":"Cancer Signaling and Metabolism Group, Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), 4200-135 Porto, Portugal"},{"name":"Abel Salazar Biomedical Sciences Institute (ICBAS), University of Porto, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0871-1427","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Vinagre","sequence":"additional","affiliation":[{"name":"Cancer Signaling and Metabolism Group, Institute for Research and Innovation in Health Sciences (i3S), University of Porto, 4200-135 Porto, Portugal"},{"name":"Cancer Signaling and Metabolism Group, Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), 4200-135 Porto, Portugal"},{"name":"Medical Faculty of University of Porto (FMUP), 4200-139 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2018,5,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1126\/science.aab3389","article-title":"Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection","volume":"350","author":"Blackburn","year":"2015","journal-title":"Science"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nsmb.3092","article-title":"Complex interactions between the DNA-damage response and mammalian telomeres","volume":"22","author":"Arnoult","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mrrev.2016.11.002","article-title":"TERT promoter mutations in telomere biology","volume":"771","author":"Heidenreich","year":"2017","journal-title":"Mutat. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13073-016-0324-x","article-title":"Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies","volume":"8","author":"Jafri","year":"2016","journal-title":"Genome Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Naderlinger, E., and Holzmann, K. (2017). Epigenetic Regulation of Telomere Maintenance for Therapeutic Interventions in Gliomas. Genes, 8.","DOI":"10.3390\/genes8050145"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00018-016-2146-9","article-title":"Reactivation of telomerase in cancer","volume":"73","author":"Akincilar","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrm2848","article-title":"Telomeres: Protecting chromosomes against genome instability","volume":"11","author":"Karlseder","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrm3505","article-title":"Finding the end: Recruitment of telomerase to telomeres","volume":"14","author":"Nandakumar","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrg1656","article-title":"Telomeres and human disease: Ageing, cancer and beyond","volume":"6","author":"Blasco","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-pathol-020712-164030","article-title":"The role of telomere biology in cancer","volume":"8","author":"Xu","year":"2013","journal-title":"Annu. Rev. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1126\/science.1218498","article-title":"Removal of shelterin reveals the telomere end-protection problem","volume":"336","author":"Sfeir","year":"2012","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1126\/science.1170633","article-title":"How telomeres solve the end-protection problem","volume":"326","year":"2009","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.celrep.2016.12.005","article-title":"Telomere Recognition and Assembly Mechanism of Mammalian Shelterin","volume":"18","author":"Erdel","year":"2017","journal-title":"Cell Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc3025","article-title":"Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins","volume":"11","author":"Martinez","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.tibs.2013.07.001","article-title":"Telomerase: Central regulator of all of the hallmarks of cancer","volume":"38","author":"Low","year":"2013","journal-title":"Trends Biochem. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/nm1006-1133","article-title":"Telomeres and telomerase: The path from maize, Tetrahymena and yeast to human cancer and aging","volume":"12","author":"Blackburn","year":"2006","journal-title":"Nat. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1349-7006.2008.00815.x","article-title":"Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells","volume":"99","author":"Cao","year":"2008","journal-title":"Cancer Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1101\/gad.263863.115","article-title":"Human telomerase: Biogenesis, trafficking, recruitment, and activation","volume":"29","author":"Schmidt","year":"2015","journal-title":"Genes Dev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1126\/science.1138596","article-title":"Protein composition of catalytically active human telomerase from immortal cells","volume":"315","author":"Cohen","year":"2007","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"20325","DOI":"10.1073\/pnas.1100279108","article-title":"Architecture of human telomerase RNA","volume":"108","author":"Zhang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1083\/jcb.201401012","article-title":"Telomeropathies: An emerging spectrum disorder","volume":"205","author":"Holohan","year":"2014","journal-title":"J. Cell Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00428-014-1608-4","article-title":"Telomerase promoter mutations in cancer: An emerging molecular biomarker?","volume":"465","author":"Vinagre","year":"2014","journal-title":"Virchows Arch."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/B978-0-12-397898-1.00004-9","article-title":"Telomere dynamics and aging","volume":"125","author":"Aubert","year":"2014","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mrfmmm.2011.11.002","article-title":"It all comes together at the ends: Telomerase structure, function, and biogenesis","volume":"730","author":"Podlevsky","year":"2012","journal-title":"Mutat. Res."},{"key":"ref_25","first-page":"1563","article-title":"Telomerase: Structure, functions, and activity regulation","volume":"75","author":"Zvereva","year":"2011","journal-title":"Biochemistry"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"15326","DOI":"10.1038\/srep15326","article-title":"The asymmetry of telomere replication contributes to replicative senescence heterogeneity","volume":"5","author":"Bourgeron","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"Blasco","year":"2013","journal-title":"Cell"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1349-7006.2008.00878.x","article-title":"Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers","volume":"99","author":"Kyo","year":"2008","journal-title":"Cancer Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"752","DOI":"10.4161\/cc.4.6.1720","article-title":"Role of Rb family in the epigenetic definition of chromatin","volume":"4","author":"Gonzalo","year":"2005","journal-title":"Cell Cycle"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/carcin\/bgh185","article-title":"Telomere epigenetics: A higher-order control of telomere length in mammalian cells","volume":"25","author":"Blasco","year":"2004","journal-title":"Carcinogenesis"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ncb1386","article-title":"DNA methyltransferases control telomere length and telomere recombination in mammalian cells","volume":"8","author":"Gonzalo","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/ng1278","article-title":"Epigenetic regulation of telomere length in mammalian cells by the SUV39H1 and SUV39H2 histone methyltransferases","volume":"36","author":"Peters","year":"2004","journal-title":"Nat. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1101\/gad.251041.114","article-title":"Telomere position effect: Regulation of gene expression with progressive telomere shortening over long distances","volume":"28","author":"Robin","year":"2014","journal-title":"Genes Dev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrg2763","article-title":"Alternative lengthening of telomeres: Models, mechanisms and implications","volume":"11","author":"Cesare","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm1197-1271","article-title":"Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines","volume":"3","author":"Bryan","year":"1997","journal-title":"Nat. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1101\/gad.205062.112","article-title":"Alternative lengthening of telomeres in normal mammalian somatic cells","volume":"27","author":"Neumann","year":"2013","journal-title":"Genes Dev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/molehr\/gaw053","article-title":"DNA methylation mediated up-regulation of TERRA non-coding RNA is coincident with elongated telomeres in the human placenta","volume":"22","author":"Novakovic","year":"2016","journal-title":"Mol. Hum. Reprod."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/path.2981","article-title":"The alternative lengthening of telomeres pathway may operate in non-neoplastic human cells","volume":"226","author":"Slatter","year":"2012","journal-title":"J. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nsmb.3078","article-title":"TERRA and the state of the telomere","volume":"22","author":"Rippe","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.trsl.2013.08.009","article-title":"Telomere biology and translational research","volume":"162","author":"Mason","year":"2013","journal-title":"Transl. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1530\/JME-16-0195","article-title":"TERT biology and function in cancer: Beyond immortalisation","volume":"58","author":"Pestana","year":"2017","journal-title":"J. Mol. Endocrinol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0959-437X(99)80014-8","article-title":"Telomere maintenance mechanisms and cellular immortalization","volume":"9","author":"Colgin","year":"1999","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biochi.2007.07.025","article-title":"Telomerase redefined: Integrated regulation of HTR and hTERT for telomere maintenance and telomerase activity","volume":"90","author":"Cairney","year":"2008","journal-title":"Biochimie"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng.3781","article-title":"Systematic analysis of telomere length and somatic alterations in 31 cancer types","volume":"49","author":"Barthel","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5987","DOI":"10.1021\/acs.jmedchem.5b01835","article-title":"Quadruplex Nucleic Acids as Novel Therapeutic Targets","volume":"59","author":"Neidle","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Jager, K., and Walter, M. (2016). Therapeutic targeting of telomerase. Genes, 7.","DOI":"10.3390\/genes7070039"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Ivancich, M., Schrank, Z., Wojdyla, L., Leviskas, B., Kuckovic, A., Sanjali, A., and Puri, N. (2017). Treating cancer by targeting telomeres and telomerase. Antioxidants, 6.","DOI":"10.3390\/antiox6010015"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1073\/pnas.1303607110","article-title":"TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal","volume":"110","author":"Killela","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00401-013-1195-5","article-title":"Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system","volume":"126","author":"Koelsche","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/ncomms3185","article-title":"Frequency of TERT promoter mutations in human cancers","volume":"4","author":"Vinagre","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_52","first-page":"6230","article-title":"Frequent amplification of the telomerase reverse transcriptase gene in human tumors","volume":"60","author":"Zhang","year":"2000","journal-title":"Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3892\/mco.2015.674","article-title":"TERT promoter mutations are rare in bone and soft tissue sarcomas of Japanese patients","volume":"4","author":"Saito","year":"2016","journal-title":"Mol. Clin. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nature14980","article-title":"Telomerase activation by genomic rearrangements in high-risk neuroblastoma","volume":"526","author":"Peifer","year":"2015","journal-title":"Nature"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.ajpath.2011.06.018","article-title":"Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes","volume":"179","author":"Heaphy","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.trecan.2015.07.007","article-title":"ALTernative telomere maintenance and cancer","volume":"1","author":"Dilley","year":"2015","journal-title":"Trends Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"29714","DOI":"10.1038\/srep29714","article-title":"TERT promoter mutations in pancreatic endocrine tumours are rare and mainly found in tumours from patients with hereditary syndromes","volume":"6","author":"Vinagre","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/bjc.2015.326","article-title":"TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast","volume":"113","author":"Yoshida","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10549-017-4156-1","article-title":"Comprehensive genomic profiling of malignant phyllodes tumors of the breast","volume":"162","author":"Nozad","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"77540","DOI":"10.18632\/oncotarget.20560","article-title":"TERT promoter status and gene copy number gains: Effect on TERT expression and association with prognosis in breast cancer","volume":"8","author":"Veronese","year":"2017","journal-title":"Oncotarget"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.18632\/oncotarget.1765","article-title":"Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas","volume":"5","author":"Killela","year":"2014","journal-title":"Oncotarget"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"10617","DOI":"10.18632\/oncotarget.3329","article-title":"TERT promoter mutations and telomere length in adult malignant gliomas and recurrences","volume":"6","author":"Heidenreich","year":"2015","journal-title":"Oncotarget"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00401-017-1690-1","article-title":"Adult infiltrating gliomas with WHO 2016 integrated diagnosis: Additional prognostic roles of ATRX and TERT","volume":"133","author":"Pekmezci","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00401-013-1141-6","article-title":"Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss","volume":"126","author":"Arita","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/neuonc\/nou158","article-title":"TERT promoter mutations: A novel independent prognostic factor in primary glioblastomas","volume":"17","author":"Simon","year":"2015","journal-title":"Neuro-Oncology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11060-016-2132-y","article-title":"Brain regions associated with telomerase reverse transcriptase promoter mutations in primary glioblastomas","volume":"128","author":"Fan","year":"2016","journal-title":"J. Neuro-Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/cns.12724","article-title":"Paradoxical prognostic impact of TERT promoter mutations in gliomas depends on different histological and genetic backgrounds","volume":"23","author":"You","year":"2017","journal-title":"CNS Neurosci. Ther."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"16663","DOI":"10.18632\/oncotarget.4389","article-title":"TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma","volume":"6","author":"Mosrati","year":"2015","journal-title":"Oncotarget"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11060-015-1999-3","article-title":"TERT promoter mutations and rs2853669 polymorphism: Prognostic impact and interactions with common alterations in glioblastomas","volume":"126","author":"Nencha","year":"2016","journal-title":"J. Neuro-Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.4161\/cc.24662","article-title":"Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma","volume":"12","author":"Liu","year":"2013","journal-title":"Cell Cycle"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","article-title":"Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors","volume":"372","author":"Lachance","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00401-013-1203-9","article-title":"TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomas","volume":"126","author":"Arita","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/neuonc\/now021","article-title":"Classification based on mutations of TERT promoter and IDH characterizes subtypes in grade II\/III gliomas","volume":"18","author":"Yang","year":"2016","journal-title":"Neuro-Oncology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1038\/bjc.2014.538","article-title":"TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations","volume":"111","author":"Labussiere","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ejca.2015.03.010","article-title":"Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation","volume":"51","author":"Huang","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/ijc.30057","article-title":"The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism","volume":"139","author":"Batista","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.18632\/oncotarget.6007","article-title":"TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40478-017-0465-1","article-title":"The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas","volume":"5","author":"Lee","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s40478-016-0351-2","article-title":"A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas","volume":"4","author":"Arita","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/nov010","article-title":"Prognostic quality of activating TERT promoter mutations in glioblastoma: Interaction with the rs2853669 polymorphism and patient age at diagnosis","volume":"17","author":"Lotsch","year":"2015","journal-title":"Neuro-Oncology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00401-013-1163-0","article-title":"TERT promoter mutations in primary and secondary glioblastomas","volume":"126","author":"Nonoguchi","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_82","first-page":"8213","article-title":"Preclinical and clinical implications of TERT promoter mutation in glioblastoma multiforme","volume":"14","author":"Jeong","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00401-013-1198-2","article-title":"TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma","volume":"126","author":"Remke","year":"2013","journal-title":"Acta Neuropathol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccr.2014.02.004","article-title":"Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition","volume":"25","author":"Kool","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00401-013-1225-3","article-title":"TERT promoter mutation and aberrant hypermethylation are associated with elevated expression in medulloblastoma and characterise the majority of non-infant SHH subgroup tumours","volume":"127","author":"Lindsey","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000448922","article-title":"Study of hTERT and Histone 3 Mutations in Medulloblastoma","volume":"84","author":"Almeida","year":"2017","journal-title":"Pathobiology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/bpa.12110","article-title":"High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression","volume":"24","author":"Goutagny","year":"2014","journal-title":"Brain Pathol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Sahm, F., Schrimpf, D., Olar, A., Koelsche, C., Reuss, D., Bissel, J., Kratz, A., Capper, D., Schefzyk, S., and Hielscher, T. (2016). TERT Promoter Mutations and Risk of Recurrence in Meningioma. J. Natl. Cancer Inst., 108.","DOI":"10.1093\/jnci\/djv377"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1167\/iovs.14-14901","article-title":"Prevalence and Implications of TERT Promoter Mutation in Uveal and Conjunctival Melanoma and in Benign and Premalignant Conjunctival Melanocytic Lesions","volume":"55","author":"Koopmans","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/bjc.2013.312","article-title":"TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours","volume":"109","author":"Griewank","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Griewank, K.G., Murali, R., Puig-Butille, J.A., Schilling, B., Livingstone, E., Potrony, M., Carrera, C., Schimming, T., Moller, I., and Schwamborn, M. (2014). TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma. JNCI J. Natl. Cancer Inst., 106.","DOI":"10.1093\/jnci\/dju246"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"5854","DOI":"10.1167\/iovs.15-17469","article-title":"Frequent TERT promoter mutations in ocular surface squamous neoplasia","volume":"56","author":"Scholz","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/bjc.2013.804","article-title":"Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: Detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma","volume":"110","author":"Dono","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ccr.2014.03.005","article-title":"Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation","volume":"25","author":"Pilati","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1038\/ncomms3218","article-title":"High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions","volume":"4","author":"Nault","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00428-014-1658-7","article-title":"Frequency of TERT promoter mutations in primary tumors of the liver","volume":"465","author":"Quaas","year":"2014","journal-title":"Virchows Arch."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Chen, C., Han, S., Meng, L., Li, Z., Zhang, X., and Wu, A. (2014). TERT promoter mutations lead to high transcriptional activity under hypoxia and temozolomide treatment and predict poor prognosis in gliomas. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100297"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/ng.3126","article-title":"Trans-ancestry mutational landscape of hepatocellular carcinoma genomes","volume":"46","author":"Totoki","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","author":"Ally","year":"2017","journal-title":"Cell"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3748\/wjg.v21.i1.311","article-title":"Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations","volume":"21","author":"Cevik","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1038\/ncomms7120","article-title":"Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity","volume":"6","author":"Fujimoto","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"69267","DOI":"10.18632\/oncotarget.12121","article-title":"Frequent somatic TERT promoter mutations and CTNNB1 mutations in hepatocellular carcinoma","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"54253","DOI":"10.18632\/oncotarget.9801","article-title":"Tumor specific mutations in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma","volume":"7","author":"Pezzuto","year":"2016","journal-title":"Oncotarget"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"27838","DOI":"10.18632\/oncotarget.8539","article-title":"Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"26288","DOI":"10.18632\/oncotarget.15458","article-title":"Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e5766","DOI":"10.1097\/MD.0000000000005766","article-title":"Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma","volume":"96","author":"Lee","year":"2017","journal-title":"Medicine"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"23120","DOI":"10.18632\/oncotarget.15498","article-title":"The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma","volume":"8","author":"Yuan","year":"2017","journal-title":"Oncotarget"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1002\/ijc.28633","article-title":"Low frequency of TERT promoter mutations in a large cohort of gallbladder and gastric cancers","volume":"134","author":"Qu","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/ijc.28360","article-title":"Low frequency of TERT promoter somatic mutation in 313 sporadic esophageal squamous cell carcinomas","volume":"134","author":"Zhao","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/ijc.28527","article-title":"Absence of TERT promoter mutations in esophageal adenocarcinoma","volume":"134","author":"Zwarthoff","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.gene.2014.02.051","article-title":"The absence of TERT promoter mutations in primary gastric cancer","volume":"540","author":"Liu","year":"2014","journal-title":"Gene"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.jhep.2014.08.009","article-title":"The genomic landscape of hepatoblastoma and their progenies with HCC-like features","volume":"61","author":"Eichenmuller","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1002\/cncr.28800","article-title":"TERT Promoter Mutation as an Early Genetic Event Activating Telomerase in Follicular Thyroid Adenoma (FTA) and Atypical FTA","volume":"120","author":"Wang","year":"2014","journal-title":"Cancer"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/ERC-13-0210","article-title":"Highly prevalent TERT promoter mutations in aggressive thyroid cancers","volume":"20","author":"Liu","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1200\/JCO.2014.55.5094","article-title":"BRAFV600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence","volume":"32","author":"Xing","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1530\/EJE-14-0837","article-title":"TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma","volume":"172","author":"Gandolfi","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.mce.2014.10.019","article-title":"Telomerase in differentiated thyroid cancer: Promoter mutations, expression and localization","volume":"399","author":"Muzza","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1530\/ERC-15-0396","article-title":"TERT promoter mutations in thyroid cancer: A report from a Middle Eastern population","volume":"22","author":"Qasem","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3803\/EnM.2016.31.1.100","article-title":"Low prevalence of somatic tert promoter mutations in classic papillary thyroid carcinoma","volume":"31","author":"Jeon","year":"2016","journal-title":"Endocrinol. Metab."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1089\/thy.2015.0488","article-title":"Prognostic significance of TERT promoter mutations in papillary thyroid carcinomas in a BRAFV600E mutation\u2013prevalent population","volume":"26","author":"Lee","year":"2016","journal-title":"Thyroid"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Sun, J., Zhang, J., Lu, J., Gao, J., Ren, X., Teng, L., Duan, H., Lin, Y., Li, X., and Zhang, B. (2016). BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma in chinese patients. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153319"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/cen.12999","article-title":"TERT promoter mutations are a major indicator of recurrence and death due to papillary thyroid carcinomas","volume":"85","author":"Bullock","year":"2016","journal-title":"Clin. Endocrinol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.1210\/jc.2013-3734","article-title":"TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas","volume":"99","author":"Melo","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1530\/ERC-15-0057","article-title":"Tall cell papillary thyroid carcinoma: New diagnostic criteria and mutations in BRAF and TERT","volume":"22","author":"Dettmer","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"E1562","DOI":"10.1210\/jc.2013-2383","article-title":"Frequent somatic TERT promoter mutations in thyroid cancer: Higher prevalence in advanced forms of the disease","volume":"98","author":"Landa","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1530\/ERC-14-0359","article-title":"Diagnostic and prognostic TERT promoter mutations in thyroid fine-needle aspiration biopsy","volume":"21","author":"Liu","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1038\/onc.2013.446","article-title":"The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas","volume":"33","author":"Liu","year":"2014","journal-title":"Oncogene"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"E1550","DOI":"10.1210\/jc.2015-2690","article-title":"Association of TERT promoter mutation, but not BRAF mutation, with increased mortality in PTC","volume":"100","author":"George","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"18346","DOI":"10.18632\/oncotarget.7811","article-title":"BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: A study of 653 patients","volume":"7","author":"Jin","year":"2016","journal-title":"Oncotarget"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1530\/ERC-16-0219","article-title":"TERT promoter mutations and long-term survival in patients with thyroid cancer","volume":"23","author":"Kim","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4143\/crt.2015.362","article-title":"TERT Promoter mutations and tumor persistence\/recurrence in papillary thyroid cancer","volume":"48","author":"Myung","year":"2016","journal-title":"Cancer Res. Treat."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/ERC-16-0421","article-title":"Comprehensive screening for PD-L1 expression in thyroid cancer","volume":"24","author":"Ahn","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1210\/jc.2016-3434","article-title":"Refining dynamic risk stratification and prognostic groups for differentiated thyroid cancer with TERT promoter mutations","volume":"102","author":"Kim","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s12020-017-1340-3","article-title":"Ultrasonographic prediction of highly aggressive telomerase reverse transcriptase (TERT) promoter-mutated papillary thyroid cancer","volume":"57","author":"Kim","year":"2017","journal-title":"Endocrine"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1210\/jc.2016-2785","article-title":"TERT, BRAF, and NRAS in primary thyroid cancer and metastatic disease","volume":"102","author":"Melo","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1530\/EJE-16-0740","article-title":"TERT promoter mutations: A genetic signature of benign and malignant thyroid tumours occurring in the context of tinea capitis irradiation","volume":"176","author":"Boaventura","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1210\/jc.2014-1634","article-title":"Clinical and molecular features of Hurthle cell carcinoma of the thyroid","volume":"100","author":"Chindris","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"E632","DOI":"10.1210\/jc.2014-3606","article-title":"Association of TERT promoter mutation 1,295,228 C>T with BRAFV600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer","volume":"100","author":"Shi","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/modpathol.2017.75","article-title":"Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: Identification of TERT mutation as an independent risk factor for transformation","volume":"30","author":"Oishi","year":"2017","journal-title":"Mod. Pathol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2967\/jnumed.116.180240","article-title":"TERT promoter mutation predicts radioiodine-refractory character in distant metastatic differentiated thyroid cancer","volume":"58","author":"Yang","year":"2017","journal-title":"J. Nucl. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1530\/ERC-14-0016","article-title":"The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors","volume":"21","author":"Liu","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s40618-016-0479-8","article-title":"Absence of TERT promoter mutations in pituitary adenomas","volume":"39","author":"Martins","year":"2016","journal-title":"J. Endocrinol. Investig."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"E1130","DOI":"10.1210\/jc.2013-4048","article-title":"TERT Promoter Mutations and Their Association with BRAFV600E Mutation and Aggressive Clinicopathological Characteristics of Thyroid Cancer","volume":"99","author":"Liu","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_147","first-page":"7988","article-title":"Cytologic, clinicopathologic, and molecular features of papillary thyroid carcinoma with prominent hobnail features: 10 case reports and systematic literature review","volume":"8","author":"Lee","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1089\/thy.2015.0101","article-title":"TERT promoter mutations in papillary thyroid microcarcinomas","volume":"25","author":"Gandolfi","year":"2015","journal-title":"Thyroid"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1089\/thy.2016.0645","article-title":"TERT promoter mutations were not found in papillary thyroid microcarcinomas that showed disease progression on active surveillance","volume":"27","author":"Yabuta","year":"2017","journal-title":"Thyroid"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/thy.2015.0510","article-title":"Uncommon TERT promoter mutations in pediatric thyroid cancer","volume":"26","author":"Alzahrani","year":"2016","journal-title":"Thyroid"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12022-016-9420-0","article-title":"Classic architecture with multicentricity and local recurrence, and absence of TERT Promoter mutations are correlates of BRAFV600E harboring pediatric papillary thyroid carcinomas","volume":"27","author":"Onder","year":"2016","journal-title":"Endocr. Pathol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/path.4315","article-title":"Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy","volume":"232","author":"Wu","year":"2014","journal-title":"J. Pathol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/modpathol.2014.93","article-title":"Molecular alterations in endometrial and ovarian clear cell carcinomas: Clinical impacts of telomerase reverse transcriptase promoter mutation","volume":"28","author":"Huang","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.anndiagpath.2015.03.005","article-title":"Heterogeneity of TERT promoter mutations status in squamous cell carcinomas of different anatomical sites","volume":"19","author":"Cheng","year":"2015","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"7907","DOI":"10.1007\/s13277-015-4694-2","article-title":"TERT promoter hot spot mutations are frequent in Indian cervical and oral squamous cell carcinomas","volume":"37","author":"Vinothkumar","year":"2016","journal-title":"Tumor Biol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/bjd.15836","article-title":"KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomas","volume":"177","author":"Selim","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/ijc.28728","article-title":"TERT promoter mutations predict worse survival in laryngeal cancer patients","volume":"135","author":"Qu","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/hed.24728","article-title":"Prevalence of promoter mutations in the TERT gene in oral cavity squamous cell carcinoma","volume":"39","author":"Chang","year":"2017","journal-title":"Head Neck"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Kim, H., Ahn, D., Sohn, J.H., Kim, Y.H., Lee, J.H., and Lee, H. (2017). TERT Promoter Mutation and Telomere Length in Salivary Gland Tumors. Pathol. Oncol. Res.","DOI":"10.1007\/s12253-017-0275-6"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Lam, G., Xian, R.R., Li, Y., Burns, K.H., and Beemon, K.L. (2016). Lack of TERT Promoter Mutations in Human B-Cell Non-Hodgkin Lymphoma. Genes, 7.","DOI":"10.3390\/genes7110093"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ajh.24324","article-title":"Acquired TERT promoter mutations stimulate TERT transcription in mantle cell lymphoma","volume":"91","author":"Panero","year":"2016","journal-title":"Am. J. Hematol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"25109","DOI":"10.18632\/oncotarget.4668","article-title":"Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis","volume":"6","author":"Mosrati","year":"2015","journal-title":"Oncotarget"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1038\/onc.2013.351","article-title":"Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma","volume":"33","author":"Tallet","year":"2014","journal-title":"Oncogene"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2014.10.009","article-title":"Recurrent TERT promoter mutations in non-small cell lung cancers","volume":"86","author":"Ma","year":"2014","journal-title":"Lung Cancer"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Yuan, P., Cao, J.L., Abuduwufuer, A., Wang, L.M., Yuan, X.S., Lv, W., and Hu, J. (2016). Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0146803"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Li, C., Hao, L., Li, Y., Wang, S., Chen, H., Zhang, L., Ke, B., Yin, Y., Suo, H., and Sun, B. (2014). Prognostic value analysis of mutational and clinicopathological factors in non-small cell lung cancer. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0107276"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.3892\/ol.2017.6284","article-title":"Mutation of the TERT promoter leads to poor prognosis of patients with non-small cell lung cancer","volume":"14","author":"Jung","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13045-014-0047-7","article-title":"High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins","volume":"7","author":"Zheng","year":"2014","journal-title":"J. Hematol. Oncol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3892\/br.2015.463","article-title":"Absence of telomerase reverse transcriptase promoter mutations in neuroblastoma","volume":"3","author":"Lindner","year":"2015","journal-title":"Biomed. Rep."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Griewank, K.G., Murali, R., Schilling, B., Schimming, T., Moller, I., Moll, I., Schwamborn, M., Sucker, A., Zimmer, L., and Schadendorf, D. (2013). TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0080354"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1038\/jid.2014.163","article-title":"TERT promoter mutations in skin cancer: The effects of sun exposure and X-irradiation","volume":"134","author":"Populo","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/modpathol.2013.167","article-title":"Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma","volume":"27","author":"Scott","year":"2014","journal-title":"Mod. Pathol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1136\/bjophthalmol-2015-307503","article-title":"TERT promoter mutations in periocular carcinomas: Implications of ultraviolet light in pathogenesis","volume":"100","author":"Lin","year":"2016","journal-title":"Br. J. Ophthalmol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00428-015-1784-x","article-title":"Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness","volume":"467","author":"Macerola","year":"2015","journal-title":"Virchows Arch."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/ijc.30042","article-title":"TERT promoter mutations in melanoma survival","volume":"139","author":"Nagore","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/cup.12323","article-title":"TERT promoter mutation is uncommon in acral lentiginous melanoma","volume":"41","author":"Liau","year":"2014","journal-title":"J. Cutan. Pathol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/CMR.0000000000000222","article-title":"Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas","volume":"26","author":"Vazquez","year":"2016","journal-title":"Melanoma Res."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1158\/1078-0432.CCR-17-0980","article-title":"MAPK pathway and tert promoter gene mutation pattern and its prognostic value in melanoma patients: A retrospective study of 2793 cases","volume":"23","author":"Bai","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_179","first-page":"134","article-title":"Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients","volume":"7","author":"Roh","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/CMR.0000000000000272","article-title":"Frequency of telomerase reverse transcripter promoter mutations in desmoplastic melanoma subtypes: Analyses of 76 cases","volume":"26","author":"Yang","year":"2016","journal-title":"Melanoma Res."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/ng.3382","article-title":"Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway","volume":"47","author":"Shain","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/CMR.0000000000000048","article-title":"Melanomas of unknown primary frequently harbor TERT-promoter mutations","volume":"24","author":"Egberts","year":"2014","journal-title":"Melanoma Res."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"11200","DOI":"10.1038\/srep11200","article-title":"TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms","volume":"5","author":"Lee","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jmoldx.2015.07.010","article-title":"Varying Mutational Alterations in Multiple Primary Melanomas","volume":"18","author":"Egberts","year":"2016","journal-title":"J. Mol. Diagn."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/pcmr.12500","article-title":"High TERT promoter mutation frequency in non-acral cutaneous metastatic melanoma","volume":"29","author":"Ekedahl","year":"2016","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/pcmr.12441","article-title":"TERT promoter mutations associate with fast-growing melanoma","volume":"29","author":"Nagore","year":"2016","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00432-016-2322-1","article-title":"Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients","volume":"143","author":"Ofner","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.1229259","article-title":"Highly recurrent TERT promoter mutations in human melanoma","volume":"339","author":"Huang","year":"2013","journal-title":"Science"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1230062","article-title":"TERT promoter mutations in familial and sporadic melanoma","volume":"339","author":"Horn","year":"2013","journal-title":"Science"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/modpathol.2013.168","article-title":"TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas","volume":"27","author":"Griewank","year":"2014","journal-title":"Mod. Pathol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"10048","DOI":"10.18632\/oncotarget.2491","article-title":"TERT promoter mutations and gene amplification: Promoting TERT expression in Merkel cell carcinoma","volume":"5","author":"Xie","year":"2014","journal-title":"Oncotarget"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jaad.2015.07.030","article-title":"Telomerase (TERT) promoter mutations are infrequent in Merkel cell carcinomas","volume":"73","author":"Chung","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1756-9966-33-33","article-title":"TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities","volume":"33","author":"Koelsche","year":"2014","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/modpathol.2016.126","article-title":"TERT promoter mutations and prognosis in solitary fibrous tumor","volume":"29","author":"Bahrami","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11060-014-1553-8","article-title":"TERT promoter mutations and BRAF mutations are rare in sporadic, and TERT promoter mutations are absent in NF1-related malignant peripheral nerve sheath tumors","volume":"120","author":"Dubbink","year":"2014","journal-title":"J. Neuro-Oncol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/ejhg.2014.195","article-title":"Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs)","volume":"23","author":"Campanella","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/ijc.29279","article-title":"TERT promoter mutations in clear cell renal cell carcinoma","volume":"136","author":"Hosen","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_199","unstructured":"Casuscelli, J., Becerra, M.F., Manley, B.J., Zabor, E.C., Reznik, E., Redzematovic, A., Arcila, M.E., Tennenbaum, D.M., Ghanaat, M., and Kashan, M. (2017). Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma. Eur. Urol. Focus."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.18632\/oncotarget.1829","article-title":"TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas","volume":"5","author":"Wang","year":"2014","journal-title":"Oncotarget"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.eururo.2013.10.038","article-title":"Telomerase reverse transcriptase gene promoter mutations help discern the origin of urogenital tumors: A genomic and molecular study","volume":"65","author":"Wu","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eururo.2013.08.052","article-title":"Telomerase reverse transcriptase promoter mutations in bladder cancer: High frequency across stages, detection in urine, and lack of association with outcome","volume":"65","author":"Allory","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.eururo.2013.08.057","article-title":"Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine","volume":"65","author":"Hurst","year":"2014","journal-title":"Eur. Urol."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"17426","DOI":"10.1073\/pnas.1310522110","article-title":"TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism","volume":"110","author":"Rachakonda","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1634\/theoncologist.2014-0391","article-title":"TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer","volume":"20","author":"Wang","year":"2015","journal-title":"Oncologist"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/bjc.2017.210","article-title":"Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine","volume":"117","author":"Descotes","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"25826","DOI":"10.18632\/oncotarget.8404","article-title":"The genetic difference between Western and Chinese urothelial cell carcinomas: Infrequent FGFR3 mutation in Han Chinese patients","volume":"7","author":"Yuan","year":"2016","journal-title":"Oncotarget"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.eururo.2017.05.032","article-title":"Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets","volume":"72","author":"Pietzak","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1158\/0008-5472.CAN-13-2498","article-title":"TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine","volume":"73","author":"Kinde","year":"2013","journal-title":"Cancer Res."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.anndiagpath.2015.06.007","article-title":"Telomerase reverse transcriptase promoter mutations in glandular lesions of the urinary bladder","volume":"19","author":"Vail","year":"2015","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/his.13318","article-title":"Comparative study of TERT promoter mutation status within spatially, temporally and morphologically distinct components of urothelial carcinoma","volume":"72","author":"Brown","year":"2018","journal-title":"Histopathology"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/modpathol.2016.53","article-title":"High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder","volume":"29","author":"Cowan","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.humpath.2016.02.009","article-title":"Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder","volume":"53","author":"Cowan","year":"2016","journal-title":"Hum. Pathol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00428-017-2164-5","article-title":"Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder","volume":"471","author":"Tregnago","year":"2017","journal-title":"Virchows Arch."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"12428","DOI":"10.18632\/oncotarget.2660","article-title":"TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCR","volume":"5","author":"Wang","year":"2014","journal-title":"Oncotarget"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2217\/fon-2016-0414","article-title":"TERT promoter mutation status in sarcomatoid urothelial carcinomas of the upper urinary tract","volume":"13","author":"Wang","year":"2017","journal-title":"Future Oncol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00428-016-2001-2","article-title":"High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma","volume":"469","author":"Nguyen","year":"2016","journal-title":"Virchows Arch."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.anndiagpath.2015.12.002","article-title":"Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications","volume":"21","author":"Kurtis","year":"2016","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_219","doi-asserted-by":"crossref","unstructured":"Priemer, D.S., Wang, M., Zhang, S., Lopez-Beltran, A., Kouba, E., Montironi, R., Davidson, D.D., MacLennan, G.T., Wang, L., and Osunkoya, A.O. (2017). Small-cell carcinomas of the urinary bladder and prostate: TERT promoter mutation status differentiates sites of malignancy and provides evidence of common clonality between small-cell carcinoma of the urinary bladder and urothelial carcinoma. Eur. Urol. Focus.","DOI":"10.1016\/j.euf.2017.03.007"},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Lack, E.E. (2007). Tumours of the adrenal glands and extraadrenal paraganglia, American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology.","DOI":"10.55418\/9781881041016"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1038\/ncomms4401","article-title":"Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma","volume":"5","author":"Heidenreich","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/ijc.29526","article-title":"Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer","volume":"137","author":"Hosen","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/path.4672","article-title":"Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression","volume":"238","author":"Piscuoglio","year":"2016","journal-title":"J. Pathol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0002-9440(10)64311-8","article-title":"hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors","volume":"162","author":"Fan","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ijc.21020","article-title":"hTERT gene copy number is not associated with hTERT RNA expression or telomerase activity in colorectal cancer","volume":"116","author":"Palmqvist","year":"2005","journal-title":"Int. J. Cancer"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1440-1746.2004.03447.x","article-title":"Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma","volume":"19","author":"Takuma","year":"2004","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_227","first-page":"518","article-title":"Amplification of TERT and TERC genes in cervical intraepithelial neoplasia and cervical cancer","volume":"35","author":"Visnovsky","year":"2014","journal-title":"Neuroendocrinol. Lett."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1600-0714.2007.00531.x","article-title":"Frequent high telomerase reverse transcriptase expression in primary oral squamous cell carcinoma","volume":"36","author":"Freier","year":"2007","journal-title":"J. Oral. Pathol. Med."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/sj.bjc.6603110","article-title":"Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer","volume":"94","author":"Zhu","year":"2006","journal-title":"Br. J. Cancer"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"21755","DOI":"10.18632\/oncotarget.4580","article-title":"Dyskerin and TERC expression may condition survival in lung cancer patients","volume":"6","author":"Penzo","year":"2015","journal-title":"Oncotarget"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jaad.2014.05.035","article-title":"TERT gene amplification is associated with poor outcome in acral lentiginous melanoma","volume":"71","author":"Diaz","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/exd.12080","article-title":"Genetic alterations in RAS-regulated pathway in acral lentiginous melanoma","volume":"22","author":"Badenas","year":"2013","journal-title":"Exp. Dermatol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/pcmr.12471","article-title":"Association of TERT promoter mutations with telomerase expression in melanoma","volume":"29","author":"Lee","year":"2016","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000111132","article-title":"Gain of 5p15.33 is associated with progression of bladder cancer","volume":"72","author":"Yamamoto","year":"2007","journal-title":"Oncology"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0165-4608(99)00135-1","article-title":"Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung","volume":"117","author":"Sugita","year":"2000","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1746-1596-7-147","article-title":"Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer","volume":"7","author":"Liu","year":"2012","journal-title":"Diagn. Pathol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2353\/ajpath.2009.090122","article-title":"Detection of genomic amplification of the human telomerase gene TERC, a potential marker for triage of women with HPV-positive, abnormal Pap smears","volume":"175","author":"Andersson","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/sj.onc.1201066","article-title":"Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer","volume":"14","author":"Soder","year":"1997","journal-title":"Oncogene"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0165-4608(01)00510-6","article-title":"Frequent gain of copy number on the long arm of chromosome 3 in human cervical adenocarcinoma","volume":"131","author":"Yang","year":"2001","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.bjc.6603253","article-title":"Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas","volume":"95","author":"Andersson","year":"2006","journal-title":"Br. J. Cancer"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/carcin\/bgp090","article-title":"Common genetic variants on 5p15.33 contribute to risk of lung adenocarcinoma in a Chinese population","volume":"30","author":"Jin","year":"2009","journal-title":"Carcinogenesis"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ajhg.2009.09.012","article-title":"A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma","volume":"85","author":"Landi","year":"2009","journal-title":"Am. J. Hum. Genet."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/ng.407","article-title":"Genome-wide association study identifies five susceptibility loci for glioma","volume":"41","author":"Shete","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/carcin\/bgp287","article-title":"Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers","volume":"31","author":"Wang","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref_245","unstructured":"Hsiung, C.A., Lan, Q., Hong, Y.C., Chen, C.J., Hosgood, H.D., Chang, I.S., Chatterjee, N., Brennan, P., Wu, C., and Zheng, W. (2010). The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet., 6."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/ng.667","article-title":"Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations","volume":"42","author":"Miki","year":"2010","journal-title":"Nat. Genet."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwq457","article-title":"Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population","volume":"173","author":"Chen","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1440-1843.2012.02165.x","article-title":"Replication of results of genome-wide association studies on lung cancer susceptibility loci in a Korean population","volume":"17","author":"Bae","year":"2012","journal-title":"Respirology"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4238\/2012.February.16.2","article-title":"Multiple variants of TERT and CLPTM1L constitute risk factors for lung adenocarcinoma","volume":"11","author":"Chen","year":"2012","journal-title":"Genet. Mol. Res."},{"key":"ref_250","first-page":"542","article-title":"Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies","volume":"15","author":"Marie","year":"2012","journal-title":"Neuro-Oncology"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/bjc.2012.329","article-title":"The TERT variant rs2736100 is associated with colorectal cancer risk","volume":"107","author":"Kinnersley","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"E118","DOI":"10.1002\/mc.21872","article-title":"Common genetic variants in TERT contribute to risk of cervical cancer in a Chinese population","volume":"51","author":"Wang","year":"2012","journal-title":"Mol. Carcinog."},{"key":"ref_253","doi-asserted-by":"crossref","unstructured":"Lan, Q., Cawthon, R., Gao, Y., Hu, W., Hosgood, H.D., Barone-Adesi, F., Ji, B.T., Bassig, B., Chow, W.H., and Shu, X. (2013). Longer telomere length in peripheral white blood cells is associated with risk of lung cancer and the rs2736100 (CLPTM1L-TERT) polymorphism in a prospective cohort study among women in China. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059230"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.lungcan.2013.01.021","article-title":"Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer\u2014A case-control study in a Chinese population","volume":"80","author":"Myneni","year":"2013","journal-title":"Lung Cancer"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s10552-013-0244-7","article-title":"Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk","volume":"24","author":"Safaeian","year":"2013","journal-title":"Cancer Causes Control"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/carcin\/bgs325","article-title":"TERT polymorphisms modify the risk of acute lymphoblastic leukemia in Chinese children","volume":"34","author":"Sheng","year":"2013","journal-title":"Carcinogenesis"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/ajh.23842","article-title":"Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms","volume":"89","author":"Jager","year":"2014","journal-title":"Am. J. Hematol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/leu.2014.48","article-title":"The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms","volume":"28","author":"Oddsson","year":"2014","journal-title":"Leukemia"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.7314\/APJCP.2014.15.6.2809","article-title":"Genetic variations in TERT-CLPTM1L genes and risk of lung cancer in a Chinese population","volume":"15","author":"Zhao","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/ijc.29590","article-title":"TERT gene harbors multiple variants associated with pancreatic cancer susceptibility","volume":"137","author":"Campa","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_261","doi-asserted-by":"crossref","unstructured":"Krahling, T., Balassa, K., Kiss, K.P., Bors, A., Batai, A., Halm, G., Egyed, M., Fekete, S., Remenyi, P., and Masszi, T. (2015). Co-occurrence of myeloproliferative neoplasms and solid tumors is attributed to a synergism between cytoreductive therapy and the common TERT polymorphism rs2736100. Cancer Epidemiol. Prev. Biomark.","DOI":"10.1158\/1055-9965.EPI-15-0805"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.4238\/2015.May.4.4","article-title":"Association of genetic polymorphisms in TERT-CLPTM1L with lung cancer in a Chinese population","volume":"14","author":"Liu","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1038\/ncomms7691","article-title":"Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms","volume":"6","author":"Tapper","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1158\/1078-0432.CCR-15-0009","article-title":"TERT Polymorphism rs2736100-C is associated with EGFR mutation-positive non-small cell lung cancer","volume":"21","author":"Wei","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.gene.2016.03.030","article-title":"Polymorphisms in human telomerase reverse transcriptase (hTERT) gene and susceptibility to gastric cancer in a Turkish population: Hospital-based case-control study","volume":"585","author":"Bayram","year":"2016","journal-title":"Gene"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2334\/josnusd.16-0108","article-title":"The role of TERT-CLPTM1L SNPs, hTERT expression and telomere length in the pathogenesis of oral squamous cell carcinoma","volume":"58","author":"Carkic","year":"2016","journal-title":"J. Oral. Sci"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s00277-016-2787-7","article-title":"TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations","volume":"95","author":"Dahlstrom","year":"2016","journal-title":"Ann. Hematol."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"26037","DOI":"10.1038\/srep26037","article-title":"Functional evaluation of TERT-CLPTM1L genetic variants associated with susceptibility of papillary thyroid carcinoma","volume":"6","author":"Ge","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/bjh.14041","article-title":"TERT rs2736100 A> C SNP and JAK2 46\/1 haplotype significantly contribute to the occurrence of JAK2V617F and CALR mutated myeloproliferative neoplasms\u2014A multicentric study on 529 patients","volume":"174","author":"Trifa","year":"2016","journal-title":"Br. J. Haematol."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1136\/gutjnl-2016-312510","article-title":"Leucocyte telomere length, genetic variants at the TERT gene region and risk of pancreatic cancer","volume":"66","author":"Bao","year":"2017","journal-title":"Gut"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng.296","article-title":"Sequence variants at the TERT-CLPTM1L locus associate with many cancer types","volume":"41","author":"Rafnar","year":"2009","journal-title":"Nat. Genet."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/CEJ.0000000000000086","article-title":"Polymorphisms in the TERT gene are associated with lung cancer risk in the Chinese Han population","volume":"23","author":"Gao","year":"2014","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.7314\/APJCP.2014.15.19.8197","article-title":"Polymorphisms of TERT and CLPTM1L and the risk of hepatocellular carcinoma in Chinese males","volume":"15","author":"Su","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1089\/gtmb.2015.0150","article-title":"Telomerase Reverse Transcriptase (TERT) Gene Variations and Susceptibility of Colorectal Cancer","volume":"19","author":"Jannuzzi","year":"2015","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3346\/jkms.2015.30.10.1423","article-title":"TERT Polymorphism rs2853669 Influences on Lung Cancer Risk in the Korean Population","volume":"30","author":"Yoo","year":"2015","journal-title":"J. Korean Med. Sci."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/gtmb.2015.0339","article-title":"Association Between Human Telomerase Reverse Transcriptase Gene Variations and Risk of Developing Breast Cancer","volume":"20","author":"Oztas","year":"2016","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"759","DOI":"10.18632\/oncotarget.6397","article-title":"Common variations in TERT-CLPTM1L locus are reproducibly associated with the risk of nasopharyngeal carcinoma in Chinese populations","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s11060-010-0506-0","article-title":"Cancer susceptibility variants and the risk of adult glioma in a US case-control study","volume":"104","author":"Egan","year":"2011","journal-title":"J. Neuro-Oncol."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00439-010-0921-5","article-title":"Genetic variants in telomere-maintaining genes and skin cancer risk","volume":"129","author":"Nan","year":"2011","journal-title":"Hum. Genet."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.canep.2012.06.008","article-title":"Selected polymorphisms of GSTP1 and TERT were associated with glioma risk in Han Chinese","volume":"36","author":"Li","year":"2012","journal-title":"Cancer Epidemiol."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1158\/1055-9965.EPI-11-0867","article-title":"Telomere length and genetic variation in telomere maintenance genes in relation to ovarian cancer risk","volume":"21","author":"Terry","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1007\/s13277-013-0947-0","article-title":"RTEL1 and TERT polymorphisms are associated with astrocytoma risk in the Chinese Han population","volume":"34","author":"Jin","year":"2013","journal-title":"Tumor Biol."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1093\/hmg\/ddt086","article-title":"Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression","volume":"22","author":"Saunders","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/gcc.22056","article-title":"Telomere length, telomere-related genes, and breast cancer risk: The breast cancer health disparities study","volume":"52","author":"Pellatt","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/01902148.2012.762436","article-title":"Significant association of 5p15.33 (TERT-CLPTM1L genes) with lung cancer in Chinese Han population","volume":"39","author":"Zhao","year":"2013","journal-title":"Exp. Lung Res."},{"key":"ref_286","doi-asserted-by":"crossref","unstructured":"Park, S.L., Fesinmeyer, M.D., Timofeeva, M., Caberto, C.P., Kocarnik, J.M., Han, Y., Love, S.A., Young, A., Dumitrescu, L., and Lin, Y. (2014). Pleiotropic associations of risk variants identified for other cancers with lung cancer risk: The PAGE and TRICL consortia. J. Natl. Cancer Inst., 106.","DOI":"10.1093\/jnci\/dju061"},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"82727","DOI":"10.18632\/oncotarget.13102","article-title":"Genetic variants in TERT are associated with risk of gastric cancer in a Chinese Han population","volume":"7","author":"Duan","year":"2016","journal-title":"Oncotarget"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/sj.bjc.6603934","article-title":"Genetic variation in five genes important in telomere biology and risk for breast cancer","volume":"97","author":"Savage","year":"2007","journal-title":"Br. J. Cancer"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1158\/1055-9965.EPI-09-0771","article-title":"Multiple genetic variants in telomere pathway genes and breast cancer risk","volume":"19","author":"Shen","year":"2010","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/mc.22043","article-title":"Genetic variations in TERT-CLPTM1L locus are associated with risk of lung cancer in chinese population","volume":"52","author":"Zhong","year":"2013","journal-title":"Mol. Carcinog."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s13277-014-2688-0","article-title":"TERT polymorphisms rs2853669 and rs7726159 influence on prostate cancer risk in Russian population","volume":"36","author":"Shadrina","year":"2015","journal-title":"Tumor Biol."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"684","DOI":"10.18632\/oncotarget.6331","article-title":"The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer","volume":"7","author":"Ko","year":"2016","journal-title":"Oncotarget"},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/CMR.0000000000000323","article-title":"Characterization of melanoma susceptibility genes in high-risk patients from Central Italy","volume":"27","author":"Pellegrini","year":"2017","journal-title":"Melanoma Res."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1158\/1055-9965.EPI-09-0323","article-title":"Polymorphisms in telomere maintenance genes and risk of lung cancer","volume":"18","author":"Choi","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00401-016-1619-0","article-title":"Frequent alternative lengthening of telomeres and ATRX loss in adult NF1-associated diffuse and high-grade astrocytomas","volume":"132","author":"Rodriguez","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/modpathol.2013.90","article-title":"The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: A multi-institutional study of 214 astrocytomas","volume":"26","author":"Abedalthagafi","year":"2013","journal-title":"Mod. Pathol."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1158\/0008-5472.CAN-06-0910","article-title":"Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma","volume":"66","author":"Chen","year":"2006","journal-title":"Cancer Res."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1750-3639.2012.00630.x","article-title":"Molecular and Morphologic Correlates of the Alternative Lengthening of Telomeres Phenotype in High-Grade Astrocytomas","volume":"23","author":"Nguyen","year":"2013","journal-title":"Brain Pathol."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1158\/1078-0432.217.11.1","article-title":"A robust assay for alternative lengthening of telomeres in tumors shows the significance of alternative lengthening of telomeres in sarcomas and astrocytomas","volume":"11","author":"Henson","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00401-014-1348-1","article-title":"Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors","volume":"128","author":"Mangerel","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/NEN.0b013e3181e576cf","article-title":"Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survival","volume":"69","author":"McDonald","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11060-017-2585-7","article-title":"Detection of the alternative lengthening of telomeres pathway in malignant gliomas for improved molecular diagnosis","volume":"135","author":"Fogli","year":"2017","journal-title":"J. Neuro-Oncol."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(03)12681-5","article-title":"Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme","volume":"361","author":"Jellinek","year":"2003","journal-title":"Lancet"},{"key":"ref_304","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/modpathol.2013.68","article-title":"Chromophobe hepatocellular carcinoma with abrupt anaplasia: A proposal for a new subtype of hepatocellular carcinoma with unique morphological and molecular features","volume":"26","author":"Wood","year":"2013","journal-title":"Mod. Pathol."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1349-7006.2008.01063.x","article-title":"Alternative lengthening of telomeres frequently occurs in mismatch repair system-deficient gastric carcinoma","volume":"100","author":"Omori","year":"2009","journal-title":"Cancer Sci."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jamcollsurg.2014.01.001","article-title":"Alternative lengthening of telomeres predicts site of origin in neuroendocrine tumor liver metastases","volume":"218","author":"Dogeas","year":"2014","journal-title":"J. Am. Coll. Surg."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"E1571","DOI":"10.1210\/jc.2014-1158","article-title":"Telomerase-dependent and independent telomere maintenance and its clinical implications in medullary thyroid carcinoma","volume":"99","author":"Wang","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_308","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1210\/jc.2007-1840","article-title":"Evaluation of telomere length maintenance mechanisms in adrenocortical carcinoma","volume":"93","author":"Else","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_309","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1053\/j.gastro.2013.10.020","article-title":"Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors","volume":"146","author":"Marinoni","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_310","first-page":"3501","article-title":"Telomere length abnormalities and telomerase RNA component expression in gastroenteropancreatic neuroendocrine tumors","volume":"35","author":"Kim","year":"2015","journal-title":"Anticancer Res."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1158\/1078-0432.CCR-16-1113","article-title":"Alternative Lengthening of Telomeres and Loss of DAXX\/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors","volume":"23","author":"Singhi","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1158\/1078-0432.CCR-16-1147","article-title":"Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival","volume":"23","author":"Kim","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/cncy.21857","article-title":"Alternative lengthening of telomeres and ATRX\/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors","volume":"125","author":"VandenBussche","year":"2017","journal-title":"Cancer Cytopathol."},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1126\/science.1207313","article-title":"Altered telomeres in tumors with ATRX and DAXX mutations","volume":"333","author":"Heaphy","year":"2011","journal-title":"Science"},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1158\/1078-0432.CCR-08-0099","article-title":"Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma","volume":"14","author":"Villa","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/IGC.0b013e31823ca017","article-title":"Prognostic Value of Alternative Lengthening of Telomeres-Associated Biomarkers in Uterine Sarcoma and Uterine Carcinosarcoma","volume":"22","author":"Lee","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"7493","DOI":"10.18632\/oncotarget.2115","article-title":"Intratumoral diversity of telomere length in individual neuroblastoma tumors","volume":"6","author":"Pezzolo","year":"2015","journal-title":"Oncotarget"},{"key":"ref_318","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1158\/1078-0432.CCR-05-0684","article-title":"Multiple mechanisms of telomere maintenance exist in liposarcomas","volume":"11","author":"Johnson","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"8918","DOI":"10.1158\/0008-5472.CAN-06-0273","article-title":"Telomere maintenance mechanisms in liposarcomas: Association with histologic subtypes and disease progression","volume":"66","author":"Costa","year":"2006","journal-title":"Cancer Res."},{"key":"ref_320","doi-asserted-by":"crossref","unstructured":"Venturini, L., Motta, R., Gronchi, A., Daidone, M., and Zaffaroni, N. (2010). Prognostic relevance of ALT-associated markers in liposarcoma: A comparative analysis. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-254"},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/modpathol.2015.67","article-title":"Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas","volume":"28","author":"Lee","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/modpathol.2015.114","article-title":"Comprehensive screening of alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas","volume":"28","author":"Liau","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/PAS.0000000000000324","article-title":"Leiomyosarcoma with Alternative Lengthening of Telomeres Is Associated with Aggressive Histologic Features, Loss of ATRX Expression, and Poor Clinical Outcome","volume":"39","author":"Liau","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/gcc.20600","article-title":"Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma","volume":"47","author":"Ohali","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/j.humpath.2015.05.019","article-title":"Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas","volume":"46","author":"Liau","year":"2015","journal-title":"Hum. Pathol."},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/neuonc\/nos083","article-title":"Telomere maintenance mechanisms in malignant peripheral nerve sheath tumors: Expression and prognostic relevance","volume":"14","author":"Venturini","year":"2012","journal-title":"Neuro-Oncology"},{"key":"ref_327","first-page":"1759","article-title":"Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma","volume":"63","author":"Ulaner","year":"2003","journal-title":"Cancer Res."},{"key":"ref_328","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1200\/JCO.2004.03.043","article-title":"Telomerase expression predicts unfavorable outcome in osteosarcoma","volume":"22","author":"Sanders","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2106\/JBJS.G.01390","article-title":"Telomere-maintenance mechanisms in soft-tissue malignant fibrous histiocytomas","volume":"91","author":"Matsuo","year":"2009","journal-title":"J. Bone Joint Surg. Am."},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/gcc.20903","article-title":"Telomere maintenance in Wilms tumors: First evidence for the presence of alternative lengthening of telomeres mechanism","volume":"50","author":"Venturini","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1002\/hep.27372","article-title":"Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis","volume":"60","author":"Nault","year":"2014","journal-title":"Hepatology"},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jhep.2014.05.028","article-title":"TERT promoter mutations: Gatekeeper and driver of hepatocellular carcinoma","volume":"61","author":"Pinyol","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13000-016-0458-6","article-title":"Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAFV600E mutation","volume":"11","author":"Bae","year":"2016","journal-title":"Diagn. Pathol."},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature"},{"key":"ref_335","first-page":"422","article-title":"Telomerase reverse transcriptase (TERT) rs2736100 polymorphism contributes to increased risk of glioma: Evidence from a meta-analysis","volume":"8","author":"Peng","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_336","doi-asserted-by":"crossref","unstructured":"Cao, J.L., Yuan, P., Abuduwufuer, A., Lv, W., Yang, Y.H., and Hu, J. (2015). Association between the TERT Genetic Polymorphism rs2853676 and Cancer Risk: Meta-Analysis of 76,108 Cases and 134,215 Controls. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0128829"},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S1470-2045(13)70110-4","article-title":"Methylation of the TERT promoter and risk stratification of childhood brain tumours: An integrative genomic and molecular study","volume":"14","author":"Choufani","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/15384101.2015.1125243","article-title":"Telomere maintenance is pivotal for high-risk neuroblastoma","volume":"15","author":"Hertwig","year":"2016","journal-title":"Cell Cycle"},{"key":"ref_340","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.jpedsurg.2016.09.042","article-title":"Telomere biology including TERT rearrangements in neuroblastoma: A useful indicator for surgical treatments","volume":"51","author":"Kawashima","year":"2016","journal-title":"J. Pediatr. Surg."},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MPH.0000000000000840","article-title":"TERT-mediated and ATRX-mediated Telomere Maintenance and Neuroblastoma","volume":"40","author":"Duan","year":"2018","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/j.jpedsurg.2009.07.046","article-title":"Telomere biology in neuroblastoma: Telomere binding proteins and alternative strengthening of telomeres","volume":"44","author":"Onitake","year":"2009","journal-title":"J.Pediatr. Surg."},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0378-1119(02)01156-3","article-title":"Molecular biology of the ETS family of transcription factors","volume":"303","author":"Oikawa","year":"2003","journal-title":"Gene"},{"key":"ref_344","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1126\/science.1260200","article-title":"TERT promoter mutations and telomerase reactivation in urothelial cancer","volume":"347","author":"Borah","year":"2015","journal-title":"Science"},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13059-015-0791-1","article-title":"A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression","volume":"16","author":"Xi","year":"2015","journal-title":"Genome Biol."},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.gde.2013.11.005","article-title":"TERT promoter mutations in cancer development","volume":"24","author":"Heidenreich","year":"2014","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_347","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1212\/WNL.0000000000000814","article-title":"Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes","volume":"83","author":"Labussiere","year":"2014","journal-title":"Neurology"},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jocn.2015.05.066","article-title":"TERT mutation in glioma: Frequency, prognosis and risk","volume":"26","author":"Yuan","year":"2016","journal-title":"J. Clin. Neurosci."},{"key":"ref_349","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.clinre.2015.07.006","article-title":"TERT promoter mutations in primary liver tumors","volume":"40","author":"Nault","year":"2016","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ijsu.2014.05.066","article-title":"TERT promoter mutation in resectable hepatocellular carcinomas: A strong association with hepatitis C infection and absence of hepatitis B infection","volume":"12","author":"Chen","year":"2014","journal-title":"Int. J. Surg."},{"key":"ref_351","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13027-017-0138-5","article-title":"Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma","volume":"12","author":"Pezzuto","year":"2017","journal-title":"Infect. Agents Cancer"},{"key":"ref_352","doi-asserted-by":"crossref","unstructured":"Melo, M., da Rocha, A.G., Vinagre, J., Sobrinho-Sim\u00f5es, M., and Soares, P. (2015). Coexistence of TERT promoter and BRAF mutations in papillary thyroid carcinoma: Added value in patient prognosis?. J. Clin. Oncol.","DOI":"10.1200\/JCO.2014.59.4614"},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000381903","article-title":"Frequency of TERT Promoter Mutations in Prostate Cancer","volume":"82","author":"Stoehr","year":"2015","journal-title":"Pathobiology"},{"key":"ref_354","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1126\/science.aao0535","article-title":"Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism","volume":"357","author":"Chiba","year":"2017","journal-title":"Science"},{"key":"ref_355","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nature07943","article-title":"The cancer genome","volume":"458","author":"Stratton","year":"2009","journal-title":"Nature"},{"key":"ref_356","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"key":"ref_357","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1101\/gr.140301.112","article-title":"Functional genomic analysis of chromosomal aberrations in a compendium of 8000 cancer genomes","volume":"23","author":"Kim","year":"2013","journal-title":"Genome Res."},{"key":"ref_358","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ng.2760","article-title":"Pan-cancer patterns of somatic copy number alteration","volume":"45","author":"Zack","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_359","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.neo.7900092","article-title":"Mapping of the gene for the human telomerase reverse transcriptase, hTERT, to chromosome 5p15. 33 by fluorescence in situ hybridization","volume":"2","author":"Bryce","year":"2000","journal-title":"Neoplasia"},{"key":"ref_360","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/sj.bjc.6690433","article-title":"Comparative genomic hybridization and chromosomal instability in solid tumours","volume":"80","author":"Rooney","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_361","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrc2771","article-title":"A census of amplified and overexpressed human cancer genes","volume":"10","author":"Santarius","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_362","first-page":"1107","article-title":"DNA copy number amplifications in human neoplasms: Review of comparative genomic hybridization studies","volume":"152","author":"Knuutila","year":"1998","journal-title":"Am. J. Pathol."},{"key":"ref_363","first-page":"6172","article-title":"Genetic analysis of benign, low-grade, and high-grade ovarian tumors","volume":"55","author":"Iwabuchi","year":"1995","journal-title":"Cancer Res."},{"key":"ref_364","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/(SICI)1098-2264(199605)16:1<46::AID-GCC7>3.0.CO;2-3","article-title":"Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer","volume":"16","author":"Arnold","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_365","first-page":"2116","article-title":"Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas","volume":"57","author":"Balsara","year":"1997","journal-title":"Cancer Res."},{"key":"ref_366","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1073\/pnas.93.1.479","article-title":"Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix","volume":"93","author":"Heselmeyer","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_367","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1098-2264(199708)19:4<233::AID-GCC5>3.0.CO;2-Y","article-title":"Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q","volume":"19","author":"Macville","year":"1997","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_368","first-page":"1801","article-title":"Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization","volume":"54","author":"Ried","year":"1994","journal-title":"Cancer Res."},{"key":"ref_369","first-page":"5086","article-title":"Identification of frequent novel genetic alterations in small cell lung carcinoma","volume":"54","author":"Levin","year":"1994","journal-title":"Cancer Res."},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/gcc.2870130307","article-title":"Identification of novel regions of altered DNA copy number in small cell lung tumors","volume":"13","author":"Levin","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_371","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0959-8049(96)00016-0","article-title":"DNA amplification on chromosome 3q26.1-q26.3 in squamous cell carcinoma of the lung detected by reverse chromosome painting","volume":"32","author":"Brass","year":"1996","journal-title":"Eur. J. Cancer"},{"key":"ref_372","first-page":"3055","article-title":"Frequent novel DNA copy number increase in squamous cell head and neck tumors","volume":"55","author":"Brzoska","year":"1995","journal-title":"Cancer Res."},{"key":"ref_373","first-page":"1010","article-title":"Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas","volume":"55","author":"Speicher","year":"1995","journal-title":"Cancer Res."},{"key":"ref_374","first-page":"5325","article-title":"Distinct patterns of chromosomal alterations in high-and low-grade head and neck squamous cell carcinomas","volume":"56","author":"Schwendel","year":"1996","journal-title":"Cancer Res."},{"key":"ref_375","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/sj.leu.2400635","article-title":"Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization","volume":"11","author":"Dierlamm","year":"1997","journal-title":"Leukemia"},{"key":"ref_376","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1098-2264(199805)22:1<79::AID-GCC11>3.0.CO;2-D","article-title":"DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma","volume":"22","author":"Anttila","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_377","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/(SICI)1097-0215(19990420)84:2<114::AID-IJC4>3.0.CO;2-Q","article-title":"DNA sequence copy number increase at 8q: A potential new prognostic marker in high-grade osteosarcoma","volume":"84","author":"Tarkkanen","year":"1999","journal-title":"Int. J. Cancer"},{"key":"ref_378","first-page":"1153","article-title":"Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker","volume":"151","author":"Larramendy","year":"1997","journal-title":"Am. J. Pathol."},{"key":"ref_379","first-page":"3230","article-title":"DNA copy number losses in chromosome 14: An early change in gastrointestinal stromal tumors","volume":"56","author":"Miettinen","year":"1996","journal-title":"Cancer Res."},{"key":"ref_380","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/gcc.10071","article-title":"Amplification of the telomerase reverse transcriptase (hTERT) gene in cervical carcinomas","volume":"34","author":"Zhang","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_381","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/COC.0000000000000012","article-title":"MYC and human telomerase gene (TERC) copy number gain in early-stage non-small cell lung cancer","volume":"38","author":"Flacco","year":"2015","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_382","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/ijc.23672","article-title":"Genomic copy number alterations as predictive markers of systemic recurrence in breast cancer","volume":"123","author":"Hwang","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_383","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0002-9440(10)63498-0","article-title":"Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia","volume":"163","author":"Janz","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_384","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0002-9440(10)62341-3","article-title":"Genomic amplification of the human telomerase gene (TERC) in pap smears predicts the development of cervical cancer","volume":"166","author":"Sommerfeld","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_385","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1017\/S146239941000147X","article-title":"Variation at the TERT locus and predisposition for cancer","volume":"12","author":"Baird","year":"2010","journal-title":"Exp. Rev. Mol. Med."},{"key":"ref_386","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/ng.254","article-title":"Lung cancer susceptibility locus at 5p15.33","volume":"40","author":"McKay","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_387","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1089\/gtmb.2013.0322","article-title":"TERT genetic polymorphism rs2736100 was associated with lung cancer: A meta-analysis based on 14,492 subjects","volume":"17","author":"Wang","year":"2013","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_388","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.1007\/s13277-014-1765-8","article-title":"Increased lung cancer risk associated with the TERT rs2736100 polymorphism: An updated meta-analysis","volume":"35","author":"Yang","year":"2014","journal-title":"Tumor Biol."},{"key":"ref_389","doi-asserted-by":"crossref","first-page":"9328","DOI":"10.3748\/wjg.v21.i31.9328","article-title":"Influence of the hTERT rs2736100 polymorphism on telomere length in gastric cancer","volume":"21","author":"Choi","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_390","doi-asserted-by":"crossref","first-page":"31972","DOI":"10.18632\/oncotarget.7777","article-title":"The association between the TERT rs2736100 AC genotype and reduced risk of upper tract urothelial carcinomas in a Han Chinese population","volume":"7","author":"Yuan","year":"2016","journal-title":"Oncotarget"},{"key":"ref_391","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3892\/mmr.2015.3410","article-title":"Association of genetic polymorphisms in the telomerase reverse transcriptase gene with prostate cancer aggressiveness","volume":"12","author":"Wu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_392","doi-asserted-by":"crossref","unstructured":"Zou, P., Gu, A., Ji, G., Zhao, L., Zhao, P., and Lu, A. (2012). The TERT rs2736100 polymorphism and cancer risk: A meta-analysis based on 25 case-control studies. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-7"},{"key":"ref_393","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.gene.2013.05.003","article-title":"Genetic variants in TERT-CLPTM1L genetic region associated with several types of cancer: A meta-analysis","volume":"526","author":"Li","year":"2013","journal-title":"Gene"},{"key":"ref_394","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/carcin\/bgq179","article-title":"Genetic variations in TERT-CLPTM1L genes and risk of squamous cell carcinoma of the head and neck","volume":"31","author":"Liu","year":"2010","journal-title":"Carcinogenesis"},{"key":"ref_395","doi-asserted-by":"crossref","unstructured":"Wu, H., Qiao, N., Wang, Y., Jiang, M., Wang, S., Wang, C., and Hu, L. (2013). Association between the telomerase reverse transcriptase (TERT) rs2736098 polymorphism and cancer risk: Evidence from a case-control study of non-small-cell lung cancer and a meta-analysis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076372"},{"key":"ref_396","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1002\/cncr.25328","article-title":"Telomere length and genetic analyses in population-based studies of endometrial cancer risk","volume":"116","author":"Prescott","year":"2010","journal-title":"Cancer"},{"key":"ref_397","doi-asserted-by":"crossref","first-page":"E176","DOI":"10.1002\/mc.21911","article-title":"Association of genetic variants of human telomerase with colorectal polyps and colorectal cancer risk","volume":"51","author":"Hofer","year":"2012","journal-title":"Mol. Carcinog."},{"key":"ref_398","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/mc.21885","article-title":"TERT\u2019s role in colorectal carcinogenesis","volume":"52","author":"Pellatt","year":"2013","journal-title":"Mol. Carcinog."},{"key":"ref_399","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10549-011-1890-7","article-title":"Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestry","volume":"132","author":"Zheng","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_400","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cancergencyto.2008.12.006","article-title":"A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer","volume":"190","author":"Varadi","year":"2009","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_401","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.18632\/oncotarget.1975","article-title":"Expression level of hTERT is regulated by somatic mutation and common single nucleotide polymorphism at promoter region in glioblastoma","volume":"5","author":"Park","year":"2014","journal-title":"Oncotarget"},{"key":"ref_402","doi-asserted-by":"crossref","first-page":"50864","DOI":"10.18632\/oncotarget.15140","article-title":"Association between rs2853669 in TERT gene and the risk and prognosis of human cancer: A systematic review and meta-analysis","volume":"8","author":"Shen","year":"2017","journal-title":"Oncotarget"},{"key":"ref_403","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/bjc.2017.486","article-title":"Telomere length and genetics are independent colorectal tumour risk factors in an evaluation of biomarkers in normal bowel","volume":"118","author":"Kartsonaki","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_404","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nature08645","article-title":"Complex landscapes of somatic rearrangement in human breast cancer genomes","volume":"462","author":"Stephens","year":"2009","journal-title":"Nature"},{"key":"ref_405","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/ng.3438","article-title":"TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors","volume":"47","author":"Valentijn","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_406","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/305245a0","article-title":"Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour","volume":"305","author":"Schwab","year":"1983","journal-title":"Nature"},{"key":"ref_407","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/1096-911X(20001201)35:6<651::AID-MPO36>3.0.CO;2-I","article-title":"Telomerase is a strong indicator for assessing the proneness to progression in neuroblastomas","volume":"35","author":"Poremba","year":"2000","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_408","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/gcc.20698","article-title":"Rearrangement of upstream sequences of the hTERT gene during cellular immortalization","volume":"48","author":"Zhao","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_409","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","article-title":"Mutational processes molding the genomes of 21 breast cancers","volume":"149","author":"Alexandrov","year":"2012","journal-title":"Cell"},{"key":"ref_410","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"ref_411","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/cncr.22132","article-title":"Telomere length is a prognostic factor in neuroblastoma","volume":"107","author":"Ohali","year":"2006","journal-title":"Cancer"},{"key":"ref_412","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2217\/fon.11.87","article-title":"Genetic stratification of neuroblastoma for treatment tailoring","volume":"7","author":"Jeison","year":"2011","journal-title":"Future Oncol."},{"key":"ref_413","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2217\/cns.15.32","article-title":"Molecular background of oligodendroglioma: 1p\/19q, IDH, TERT, CIC and FUBP1","volume":"4","author":"Cahill","year":"2015","journal-title":"CNS Oncol."},{"key":"ref_414","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.956839","article-title":"Epigenetic modifications: Basic mechanisms and role in cardiovascular disease","volume":"123","author":"Handy","year":"2011","journal-title":"Circulation"},{"key":"ref_415","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pharmthera.2017.02.011","article-title":"Epigenetics in cancer: Fundamentals and Beyond","volume":"173","author":"Biswas","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_416","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1042\/CBI20110046","article-title":"A challenging epigenetic message: Telomerase activity is associated with complex changes in lifestyle","volume":"35","author":"Falus","year":"2011","journal-title":"Cell Biol. Int."},{"key":"ref_417","doi-asserted-by":"crossref","first-page":"E513","DOI":"10.1073\/pnas.1107759108","article-title":"Stress exposure in intrauterine life is associated with shorter telomere length in young adulthood","volume":"108","author":"Entringer","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_418","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biopsych.2012.06.025","article-title":"Telomeres and early-life stress: An overview","volume":"73","author":"Price","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"ref_419","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mrfmmm.2011.08.003","article-title":"Telomeres and lifestyle factors: Roles in cellular aging","volume":"730","author":"Lin","year":"2012","journal-title":"Mutat. Res. Fundam. Mol. Mech. Mutagen."},{"key":"ref_420","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fgene.2016.00083","article-title":"Regulation of the Telomerase Reverse Transcriptase Subunit through Epigenetic Mechanisms","volume":"7","author":"Lewis","year":"2016","journal-title":"Front. Genet."},{"key":"ref_421","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2217\/epi.11.71","article-title":"Epigenetic diet: Impact on the epigenome and cancer","volume":"3","author":"Hardy","year":"2011","journal-title":"Epigenomics"},{"key":"ref_422","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1126\/science.1063852","article-title":"The role of DNA methylation in mammalian epigenetics","volume":"293","author":"Jones","year":"2001","journal-title":"Science"},{"key":"ref_423","first-page":"1074","article-title":"Association of p16 gene methylation with prostate cancer risk: A meta-analysis","volume":"20","author":"Feng","year":"2015","journal-title":"J. BUON"},{"key":"ref_424","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.1073\/pnas.95.12.6870","article-title":"Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma","volume":"95","author":"Herman","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_425","doi-asserted-by":"crossref","unstructured":"Li, X., Yao, X., Wang, Y., Hu, F., Wang, F., Jiang, L., Liu, Y., Wang, D., Sun, G., and Zhao, Y. (2013). MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular features. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059064"},{"key":"ref_426","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.bcp.2004.04.030","article-title":"DNA methylation and breast cancer","volume":"68","author":"Szyf","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"ref_427","first-page":"537","article-title":"Methylation of the human telomerase gene CpG island","volume":"60","author":"Dessain","year":"2000","journal-title":"Cancer Res."},{"key":"ref_428","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0014-4827(03)00281-7","article-title":"Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres","volume":"289","author":"Guilleret","year":"2003","journal-title":"Exp. Cell Res."},{"key":"ref_429","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/ijc.10593","article-title":"Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity","volume":"101","author":"Guilleret","year":"2002","journal-title":"Int. J. Cancer"},{"key":"ref_430","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3109\/13547500903225912","article-title":"hTERT methylation and expression in gastric cancer","volume":"14","author":"Gigek","year":"2009","journal-title":"Biomarkers"},{"key":"ref_431","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ygyno.2004.01.036","article-title":"Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer","volume":"93","author":"Widschwendter","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"ref_432","first-page":"881","article-title":"DNA methylation is not likely to be responsible for hTERT expression in premalignant cervical lesions","volume":"232","author":"Oikonomou","year":"2007","journal-title":"Exp. Biol. Med."},{"key":"ref_433","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/JID.2015.374","article-title":"Telomerase Expression by Aberrant Methylation of the TERT Promoter in Melanoma Arising in Giant Congenital Nevi","volume":"136","author":"Fan","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_434","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/nar\/gkl1125","article-title":"Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene","volume":"35","author":"Renaud","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"ref_435","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2013.07.014","article-title":"An unbiased in vivo screen reveals multiple transcription factors that control HPV E6-regulated hTERT in keratinocytes","volume":"446","author":"Xu","year":"2013","journal-title":"Virology"},{"key":"ref_436","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3892\/ol.2011.386","article-title":"hTERT methylation is necessary but not sufficient for telomerase activity in colorectal cells","volume":"2","author":"Bougel","year":"2011","journal-title":"Oncol. Lett."},{"key":"ref_437","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0301-472X(01)00760-3","article-title":"CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia","volume":"30","author":"Bechter","year":"2002","journal-title":"Exp. Hematol."},{"key":"ref_438","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bbrc.2007.07.051","article-title":"Site-specific methylation of CpG nucleotides in the hTERT promoter region can control the expression of hTERT during malignant progression of colorectal carcinoma","volume":"361","author":"Choi","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_439","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1245\/s10434-009-0333-8","article-title":"Positive regulation of human telomerase reverse transcriptase gene expression and telomerase activity by DNA methylation in pancreatic cancer","volume":"16","author":"Kumari","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"ref_440","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/gcc.20341","article-title":"CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer","volume":"45","author":"Kim","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_441","first-page":"391","article-title":"Epigenetic regulation of hTERT promoter in hepatocellular carcinomas","volume":"34","author":"Iliopoulos","year":"2009","journal-title":"Int. J. Oncol."},{"key":"ref_442","doi-asserted-by":"crossref","first-page":"57726","DOI":"10.18632\/oncotarget.10639","article-title":"A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: A retrospective cohort study","volume":"7","author":"Leao","year":"2016","journal-title":"Oncotarget"},{"key":"ref_443","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2217\/fon-2017-0167","article-title":"The TERT hypermethylated oncologic region predicts recurrence and survival in pancreatic cancer","volume":"13","author":"Faleiro","year":"2017","journal-title":"Future Oncol."},{"key":"ref_444","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0092-8674(93)90234-H","article-title":"An alternative pathway for yeast telomere maintenance rescues est1\u2212 senescence","volume":"73","author":"Lundblad","year":"1993","journal-title":"Cell"},{"key":"ref_445","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1002\/j.1460-2075.1995.tb00098.x","article-title":"Telomere Elongation in Immortal Human-Cells without Detectable Telomerase Activity","volume":"14","author":"Bryan","year":"1995","journal-title":"EMBO J."},{"key":"ref_446","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/82586","article-title":"Telomere maintenance by recombination in human cells","volume":"26","author":"Dunham","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_447","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nature20099","article-title":"Break-induced telomere synthesis underlies alternative telomere maintenance","volume":"539","author":"Dilley","year":"2016","journal-title":"Nature"},{"key":"ref_448","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0959-8049(97)00065-8","article-title":"Telomere dynamics and telomerase activity in in vitro immortalised human cells","volume":"33","author":"Bryan","year":"1997","journal-title":"Eur. J. Cancer"},{"key":"ref_449","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1128\/MCB.21.12.3862-3875.2001","article-title":"Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells","volume":"21","author":"Perrem","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"ref_450","first-page":"4175","article-title":"Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body","volume":"59","author":"Yeager","year":"1999","journal-title":"Cancer Res."},{"key":"ref_451","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1242\/jcs.148296","article-title":"PML induces compaction, TRF2 depletion and DNA damage signaling at telomeres and promotes their alternative lengthening","volume":"128","author":"Osterwald","year":"2015","journal-title":"J. Cell Sci."},{"key":"ref_452","doi-asserted-by":"crossref","first-page":"9948","DOI":"10.1128\/MCB.24.22.9948-9957.2004","article-title":"Telomeric DNA in ALT cells is characterized by free telomeric circles and heterogeneous T-loops","volume":"24","author":"Cesare","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"ref_453","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1016\/j.febslet.2010.06.009","article-title":"Assaying and investigating Alternative Lengthening of Telomeres activity in human cells and cancers","volume":"584","author":"Henson","year":"2010","journal-title":"FEBS Lett."},{"key":"ref_454","doi-asserted-by":"crossref","unstructured":"Amorim, J.P., Santos, G., Vinagre, J., and Soares, P. (2016). The Role of ATRX in the Alternative Lengthening of Telomeres (ALT) Phenotype. Genes, 7.","DOI":"10.3390\/genes7090066"},{"key":"ref_455","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"key":"ref_456","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1593\/tlo.11202","article-title":"Expression of telomeres in astrocytoma WHO grade 2 to 4: TERRA level correlates with telomere length, telomerase activity, and advanced clinical grade","volume":"5","author":"Sampl","year":"2012","journal-title":"Transl. Oncol."},{"key":"ref_457","doi-asserted-by":"crossref","unstructured":"Hung, N., Chen, Y.J., Taha, A., Olivecrona, M., Boet, R., Wiles, A., Warr, T., Shaw, A., Eiholzer, R., Baguley, B.C., Eccles, M.R., Braithwaite, A.W., Macfarlane, M., Royds, J.A., and Slatter, T. (2014). Increased paired box transcription factor 8 has a survival function in glioma. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-159"},{"key":"ref_458","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/modpathol.2015.156","article-title":"Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastoma","volume":"29","author":"Hung","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_459","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/gcc.20074","article-title":"Divergent patterns of telomere maintenance mechanisms among human sarcomas: Sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing\u2019s sarcomas and osteosarcomas","volume":"41","author":"Ulaner","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_460","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1755-8166-1-20","article-title":"Unusually stable abnormal karyotype in a highly aggressive melanoma negative for telomerase activity","volume":"1","author":"Gagos","year":"2008","journal-title":"Mol. Cytogenet."},{"key":"ref_461","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.celrep.2017.05.046","article-title":"Highly aggressive metastatic melanoma cells unable to maintain telomere length","volume":"19","author":"Viceconte","year":"2017","journal-title":"Cell Rep."},{"key":"ref_462","doi-asserted-by":"crossref","unstructured":"Royds, J.A., Al Nadaf, S., Wiles, A.K., Chen, Y.J., Ahn, A., Shaw, A., Bowie, S., Lam, F., Baguley, B.C., and Braithwaite, A.W. (2011). The CDKN2A G500 allele is more frequent in GBM patients with no defined telomere maintenance mechanism tumors and is associated with poorer survival. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0026737"},{"key":"ref_463","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ncb1685","article-title":"Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II","volume":"10","author":"Schoeftner","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"ref_464","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1038\/emboj.2009.166","article-title":"TERRA: Telomeric repeat-containing RNA","volume":"28","author":"Luke","year":"2009","journal-title":"EMBO J."},{"key":"ref_465","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1126\/science.1147182","article-title":"Telomeric repeat\u2013containing RNA and RNA surveillance factors at mammalian chromosome ends","volume":"318","author":"Azzalin","year":"2007","journal-title":"Science"},{"key":"ref_466","doi-asserted-by":"crossref","unstructured":"MacNeil, D.E., Bensoussan, H.J., and Autexier, C. (2016). Telomerase Regulation from Beginning to the End. Genes, 7.","DOI":"10.3390\/genes7090064"},{"key":"ref_467","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrg3722","article-title":"The rise of regulatory RNA","volume":"15","author":"Morris","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"ref_468","doi-asserted-by":"crossref","first-page":"12534","DOI":"10.1038\/ncomms12534","article-title":"Telomeric RNAs are essential to maintain telomeres","volume":"7","author":"Montero","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_469","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jmr.2521","article-title":"TERRA mimicking ssRNAs prevail over the DNA substrate for telomerase in vitro due to interactions with the alternative binding site","volume":"29","author":"Azhibek","year":"2016","journal-title":"J. Mol. Recognit."},{"key":"ref_470","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.molcel.2009.06.025","article-title":"TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres","volume":"35","author":"Deng","year":"2009","journal-title":"Mol. Cell"},{"key":"ref_471","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fgene.2015.00143","article-title":"Telomeric repeat-containing RNA TERRA: A noncoding RNA connecting telomere biology to genome integrity","volume":"6","author":"Cusanelli","year":"2015","journal-title":"Front. Genet."},{"key":"ref_472","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1093\/nar\/gkq296","article-title":"The non-coding RNA TERRA is a natural ligand and direct inhibitor of human telomerase","volume":"38","author":"Redon","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"ref_473","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1038\/ncomms5723","article-title":"Identification of TERRA locus unveils a telomere protection role through association to nearly all chromosomes","volume":"5","author":"Grana","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_474","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1126\/science.1257216","article-title":"Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors","volume":"347","author":"Flynn","year":"2015","journal-title":"Science"},{"key":"ref_475","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1038\/ncomms6220","article-title":"RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells","volume":"5","author":"Arora","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_476","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/nsmb.2364","article-title":"Telomere length regulates TERRA levels through increased trimethylation of telomeric H3K9 and HP1alpha","volume":"19","author":"Arnoult","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_477","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1038\/ncomms6379","article-title":"Functional characterization of the TERRA transcriptome at damaged telomeres","volume":"5","author":"Porro","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_478","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.molcel.2013.08.029","article-title":"Telomeric noncoding RNA TERRA is induced by telomere shortening to nucleate telomerase molecules at short telomeres","volume":"51","author":"Cusanelli","year":"2013","journal-title":"Mol. Cell"},{"key":"ref_479","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/nar\/gkn1030","article-title":"Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription","volume":"37","author":"Ng","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_480","doi-asserted-by":"crossref","unstructured":"Lovejoy, C.A., Li, W., Reisenweber, S., Thongthip, S., Bruno, J., de Lange, T., De, S., Petrini, J.H., Sung, P.A., and Jasin, M. (2012). Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet., 8.","DOI":"10.1371\/journal.pgen.1002772"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/9\/5\/241\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:03:11Z","timestamp":1760194991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/9\/5\/241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,3]]},"references-count":480,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5]]}},"alternative-id":["genes9050241"],"URL":"https:\/\/doi.org\/10.3390\/genes9050241","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,3]]}}}